James J. Mauzey, 45 years old, was named chief executive, succeeding Charles A. Faden, 63, who retired.
Alteon, a biotechnology company developing products to treat complications from diabetes and aging, said Jere Goyan, 63, will remain president and chief operating officer.
Mr. Goyan had been acting chief executive since Mr. Faden announced in August that he planned to retire, effective Dec. 31.
Mr. Mauzey was president for corporate hospital accounts at Bristol-Myers Squibb Co. of New York.
